Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Butterfly Network, Inc. | General Counsel & Corp Sec | Class A Common Stock | 383,512 | $391 K | $1.02 | Mar 22, 2022 | Direct |
Acrivon Therapeutics, Inc. | Chief Legal Officer | Common Stock | 39,709 | $332 K | $8.36 | May 14, 2024 | Direct |
Acrivon Therapeutics, Inc. | Chief Legal Officer | Stock Option (Right to Buy) | 11,576 | Sep 26, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ACRV | Acrivon Therapeutics, Inc. | May 14, 2024 | 1 | -1,538 | 4 | May 16, 2024 | Chief Legal Officer |
ACRV | Acrivon Therapeutics, Inc. | Apr 17, 2024 | 1 | -5,770 | 4 | Apr 19, 2024 | Chief Legal Officer |
ACRV | Acrivon Therapeutics, Inc. | Feb 14, 2024 | 1 | -738 | 4 | Feb 16, 2024 | Chief Legal Officer |
ACRV | Acrivon Therapeutics, Inc. | Jan 17, 2024 | 1 | -2,836 | 4 | Jan 19, 2024 | Chief Legal Officer |
ACRV | Acrivon Therapeutics, Inc. | Nov 14, 2023 | 1 | -3,734 | 4 | Nov 16, 2023 | Chief Legal Officer |
ACRV | Acrivon Therapeutics, Inc. | Oct 17, 2023 | 1 | -12,231 | 4 | Oct 19, 2023 | Chief Legal Officer |
ACRV | Acrivon Therapeutics, Inc. | Sep 26, 2023 | 2 | 0 | 4 | Sep 28, 2023 | Chief Legal Officer |
ACRV | Acrivon Therapeutics, Inc. | Sep 26, 2023 | 0 | 0 | 3 | Sep 28, 2023 | Chief Legal Officer |
BFLY | Butterfly Network, Inc. | Mar 22, 2022 | 1 | 0 | 4 | Mar 24, 2022 | General Counsel & Corp Sec |
BFLY | Butterfly Network, Inc. | Mar 4, 2022 | 1 | 0 | 4 | Mar 8, 2022 | General Counsel & Corp Sec |
BFLY | Butterfly Network, Inc. | Feb 16, 2022 | 1 | -99,253 | 4 | Feb 17, 2022 | General Counsel & Corp Sec |